Regulation of Muscle Mass by Follistatin and Activins
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Myostatin is a TGF-β family member that normally acts to limit skeletal muscle mass. Follistatin is a myostatin-binding protein that can inhibit myostatin activity in vitro and promote muscle growth in vivo. Mice homozygous for a mutation in the Fst gene have been shown to die immediately after birth but have a reduced amount of muscle tissue, consistent with a role for follistatin in regulating myogenesis. Here, we show that Fst mutant mice exhibit haploinsufficiency, with muscles of Fst heterozygotes having significantly reduced size, a shift toward more oxidative fiber types, an impairment of muscle remodeling in response to cardiotoxin-induced injury, and a reduction in tetanic force production yet a maintenance of specific force. We show that the effect of heterozygous loss of Fst is at least partially retained in a Mstn-null background, implying that follistatin normally acts to inhibit other TGF-β family members in addition to myostatin to regulate muscle size. Finally, we present genetic evidence suggesting that activin A may be one of the ligands that is regulated by follistatin and that functions with myostatin to limit muscle mass. These findings potentially have important implications with respect to the development of therapeutics targeting this signaling pathway to preserve muscle mass and prevent muscle atrophy in a variety of inherited and acquired forms of muscle degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We and others have previously demonstrated that growth differentiation factor-8 (GDF8; also known as myostatin) and activin A (ActA) are the two major ligands mediating the muscle-minimization actions of ActRIIA/B receptors22,26–30.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The function of MSTN in muscle is at least partially redundant with that of another TGF-β family member, activin A (13–16).”
From Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight (2020) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FST acts as an inhibitor of members of the TGF-β superfamily, including myostatin and activins [185,186], and can function as a promoter of skeletal muscle growth [187].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [187]
In the citing paper
“Both follistatin and GASPs inhibit the activities of GDF11 and myostatin; accordingly, follistatin (Fst)-heterozygous47 and Gasp1-null or Gasp2-null48 mice have smaller muscles and increased GDF11 and myostatin bioactivity.”
From The central role of muscle stem cells in regenerative failure with aging (2015) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Self-citationRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 3×
“Follistatin is a potent myostatin inhibitor that can cause dramatic increases in muscle mass when overexpressed as a transgene in mice (18, 21, 22).”
BackgroundSelf-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Self-citationClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice carrying the targeted allele were crossed to EIIa-cre transgenic mice (33) to generate mice in which recombination had occurred between the outside LoxP sites (denoted by triangles), thereby resulting in a mutant allele in which exons 3–5 were completely deleted in the germline.”
MethodInduction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907
Self-citationThe regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832
Cited by
Items 101–200 of 277
Khalafi, M., Aria, B., Symonds, M. E., & Rosenkranz, S. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114272 · Cited by 59
Barnett, C. F., Moreno‐Ulloa, A., Shiva, S., Ramírez‐Sánchez, I., Taub, P. R., Su, Y., Ceballos, G. M., Dugar, S., Schreiner, G. F., & Villarreal, F. J. (2015) · Food & Function · doi:10.1039/c4fo00596a · Cited by 45
Hoogaars, W. M. H., & Jaspers, R. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_8 · Cited by 45
Feeley, B. T., Liu, M., Benjamin, C., Agha, O., Aung, M. S., Lee, C. S., & Liu, X. (2020) · The American Journal of Sports Medicine · doi:10.1177/0363546520935855 · Cited by 43
“Brown and beige fat have been shown to secrete anabolic and myogenic factors, such as follistatin.(2,29,38,41,42,44,52) Mice FAPs have demonstrated the ability to adopt a beige fat phenotype characterized by elevated expression of UCP1.”
BackgroundCardiac ageing: from hallmarks to therapeutic opportunities
Hastings, M. H., Zhou, Q., Wu, C., Shabani, P., Huang, S., Yu, X., Singh, A. P., Guseh, J. S., Li, H., Lerchenmüller, C., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae124 · Cited by 53
Microfluidic Quantitative PCR Detection of 12 Transgenes from Horse Plasma for Gene Doping Control
Tozaki, T., Ohnuma, A., Kikuchi, M., Ishige, T., Kakoi, H., HIROTA, K.-I., Kusano, K., & NAGATA, S.-I. (2020) · Genes · doi:10.3390/genes11040457 · Cited by 39
“Vertical axis is assays; CKM, EPO, FGF2, FST, GH1, IGF1, MSTN, PCK1, PDK4, PPARD, VEGF and ZFAT for SET1 (A) and SET2 (B) detections.”
BackgroundInfluentialThe extraocular muscle stem cell niche is resistant to ageing and disease
Formicola, L., Marazzi, G., & Sassoon, D. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00328 · Cited by 45
“, under review) described recently that PICs express promyogenic factors, such as FST and IGF-1, which are able to counteract the antimyogenic effect exerted by MST and other TGFβ superfamily members, including activins (Amthor et al., 2004; Latres et al., 2005; Lee et al., 2010).”
BackgroundOhsawa, Y., Okada, T., Nishimatsu, S., Ishizaki, M., Suga, T., Fujino, M., Murakami, T., Uchino, M., Tsuchida, K., Noji, S., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.78 · Cited by 38
Self-citationUpdated concept of sarcopenia based on muscle–bone relationship
Yakabe, M., Hosoi, T., Akishita, M., & Ogawa, S. (2019) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-019-01048-2 · Cited by 40
Cardiokines as Modulators of Stress-Induced Cardiac Disorders
Planavila, A., Fernández‐Solà, J., & Villarroya, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.002 · Cited by 43
Vitamin D ameliorates adipose browning in chronic kidney disease cachexia
Cheung, W. W., Ding, W. Q., Hoffman, H. M., Wang, Z., Sheng, H., Zheng, R., Gonzalez, A., Zhan, J., Zhou, P. H., Li, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70190-z · Cited by 36
Rindt, H., Buckley, D. M., Vale, S. M., Krogman, M. M., Rose, F. F., Garcia, M. L., & Lorson, C. L. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.10.012 · Cited by 37
Li, J., Fredericks, M., Cannell, M., Wang, K., Sako, D., Maguire, M. C., Grenha, R., Liharska, K., Krishnan, L., Bloom, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138634 · Cited by 31
“Importantly, we show that ActRIIB:ALK4-Fc treatment differentiation factor 8 (GDF8; also known as myostatin, MSTN) were discovered to produce a muscular hypertrophy phenotype (15, 16), it expanded the possibilities for the treatment of NMDs.”
BackgroundLi, K., Zhang, Z., Mei, Y., Yang, Q., Qiao, S., Ni, C., Yao, Y., Li, X., Li, M., Wei, D., et al. (2021) · Theranostics · doi:10.7150/thno.51976 · Cited by 32
“Furthermore, activin A can reproduce the biological action of myostatin on muscle tissues because it binds to the receptors shared with myostatin [44].”
Myocardial myostatin in spontaneously hypertensive rats with heart failure
Damatto, R. L., Lima, A. R. R., Martinez, P. F., Cezar, M. D. M., Okoshi, K., & Okoshi, M. P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.101 · Cited by 32
“One of the most extensively studied and potent myostatin antagonists is follistatin [28-30].”
BackgroundMarino, F. E., Risbridger, G. P., & Gold, E. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12031 · Cited by 30
Singh, R., Pervin, S., Lee, S., Kuo, A., Grijalva, V. R., David, J., Vergnes, L., & Reddy, S. T. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s159315 · Cited by 30
“3 Several genetic studies have demonstrated an essential role for Fst in skeletal muscle development 3–6 ; however, the role of Fst in other metabolic tissues is poorly understood.”
Self-citationFollistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
Castonguay, R., Lachey, J. L., Wallner, S., Strand, J., Liharska, K., Watanabe, A. E., Cannell, M., Davies, M. V., Sako, D., Troy, M., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252304 · Cited by 30
“Early investigation of muscle regulation by TGF-b superfamily ligands used mice with haploinsufficiency or overexpression of follistatin and thereby demonstrated its strong hypertrophic effects (Lee and McPherron, 2001; Lee, 2007; Gilson et al., 2009; Lee et al., 2010).”
BackgroundInfluentialHillege, M. M., Shi, A., Galli, R., Wu, G., Bertolino, P., Hoogaars, W. M. H., & Jaspers, R. T. (2022) · eLife · doi:10.7554/elife.77610 · Cited by 29
Brinkoetter, M., Magkos, F., Vamvini, M., & Mantzoros, C. S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00146.2011 · Cited by 28
“Activin A is probably another ligand regulated by follistatin that functions with myostatin to limit muscle mass (19).”
BackgroundInfluentialThe Role of Supporting Cell Populations in Satellite Cell Mediated Muscle Repair
Johnson, A. L., Kamal, M. J., & Parise, G. (2023) · Cells · doi:10.3390/cells12151968 · Cited by 34
Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening
Nam, J., Perera, P., Gordon, R., Jeong, Y. H., Blazek, A. D., Kim, D., Tee, B. C., Sun, Z., Eubank, T. D., Zhao, Y., et al. (2015) · Bone · doi:10.1016/j.bone.2015.04.038 · Cited by 30
“The role of FST and FSTL1 in bone formation is as yet unclear; nevertheless, gene deletion studies show that FST and FSTL1 are associated with embryonic bone and muscle formation (40, 51).”
BackgroundResultInfluentialMuscle growth in teleost fish is regulated by factors utilizing the activin II B receptor
Phelps, M., Jaffe, I. M., & Bradley, T. M. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.086660 · Cited by 33
“…for fish species capable of indeterminate growth (i.e. non-growth limited) following injection or submersion in a bath of a soluble form of the Acvr2b (Carpio et al., 2009) or myostatin pro-domain (Lee et al., 2010a); however, this research was limited to only larval and early juvenile life stages.”
BackgroundAnastasilakis, A. D., Pοlyzos, S. A., Skouvaklidou, E. C., Kynigopoulos, G., Saridakis, Z. G., Apostolou, A., Triantafyllou, G. A., Karagiozoglou‐Lampoudi, Τ., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.002 · Cited by 26
“Follistatin has been proposed to regulate muscle and adipose tissue growth through activin and myostatin inhibition [1-3, 5].”
BackgroundResultInfluentialKorzun, T., Moses, A. S., Kim, J., Patel, S., Schumann, C., Levasseur, P. R., Diba, P., Olson, B. G., Rebola, K. G. D. O., Norgard, M. A., et al. (2022) · Small · doi:10.1002/smll.202204436 · Cited by 28
McIntosh, M. C., Sexton, C. L., Godwin, J. S., Ruple, B. A., Michel, J. M., Plotkin, D. L., Ziegenfuss, T. N., Lopez, H. L., Smith, R. C., Dwaraka, V. B., et al. (2023) · Cells · doi:10.3390/cells12060898 · Cited by 32
“FSTL3 similarly inhibits myostatin and activin A, which suppresses their functionality and promotes muscle growth [43,44].”
BackgroundA Soluble Activin Receptor Type IIB Does Not Improve Blood Glucose in Streptozotocin-Treated Mice
Wang, Q., Guo, T., Portas, J., & McPherron, A. C. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10430 · Cited by 25
Lodberg, A., van der Eerden, B. C. J., Boers-Sijmons, B., Thomsen, J. S., Brüel, A., van Leeuwen, J. P. T. M., & Eijken, M. (2019) · The FASEB Journal · doi:10.1096/fj.201801969rr · Cited by 25
Takayama, K., Rentier, C., Asari, T., Nakamura, A., Saga, Y., Shimada, T., Nirasawa, K., Sasaki, E., Muguruma, K., Taguchi, A., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00168 · Cited by 23
Identification of frailty and sarcopenia in hospitalised older people
Echeverria, I., Besga, A., Sanz, B., Amasene, M., Hervás, G., Barroso, J., Rodriguez‐Larrad, A., & Irazusta, J. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13420 · Cited by 30
Significance of serum Myostatin in hemodialysis patients
Esposito, P. B., Battaglia, Y., Porta, E. L., Grignano, M. A., Caramella, E., Avella, A., Peressini, S., Sessa, N., Albertini, R., Natali, G. D., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1647-9 · Cited by 26
Hulmi, J. J., Nissinen, T. A., Penna, F., & Bonetto, A. (2021) · Cells · doi:10.3390/cells10030516 · Cited by 24
“Discovery and Function The Transforming Growth Factor β (TGF‐β) superfamily consists of more than 30 growth factors representing TGF‐βs, growth and differentiation factors (GDFs), bone mor‐ phogenetic proteins (BMPs), activins and nodal [112].”
BackgroundResultInfluentialDasarathy, S., Muc, S., Runkana, A., Mullen, K. D., Kaminsky-Russ, K., & McCullough, A. J. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2011 · Cited by 23
“Even though follistatin binds to other proteins, including activin, its dominant effect, at least, in the skeletal muscle, is due to inhibition of myostatin (6, 24, 28).”
BackgroundGarcía-Merino, J. Á., Moreno‐Pérez, D., de Lucas, B., Montalvo-Lominchar, M. G., Muñoz, E., Sánchez, L. M. M., Naclerio, F., Herrera-Rocha, K. M., Moreno‐Jiménez, M. R., Rocha‐Guzmán, N. E., et al. (2020) · Food & Function · doi:10.1039/d0fo00246a · Cited by 25
Emerging Roles of Non-Coding RNAs in the Feed Efficiency of Livestock Species
Hu, G., Do, D. N., Davoudi, P., & Miar, Y. (2022) · Genes · doi:10.3390/genes13020297 · Cited by 24
Upadhaya, S. D., Chung, T. K., Jung, Y. J., & Kim, I. H. (2021) · Animal Bioscience · doi:10.5713/ab.21.0304 · Cited by 23
“The MSTN gene was significantly down-regulated (p 0.05) whereas MYOD and MYF5 genes (p 0.05) were upregulated for pigs born to sows receiving 25(OH)D3 supplemented diets during gestation and lactation.”
BackgroundInfluentialRecent advances in the crosstalk between adipose, muscle and bone tissues in fish
Hue, I., Capilla, E., Rosell-Moll, E., Balbuena-Pecino, S., Goffette, V., Gabillard, J., & Navarro, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1155202 · Cited by 23
Tarabeih, N., Kalinkovich, A., Shalata, A., Higla, O., & Livshits, G. (2023) · Biomolecules · doi:10.3390/biom13091315 · Cited by 22
“The myokine glycoprotein follistatin, which shares some structural homology with FSTL1 [72] and acts as a decoy receptor for activins [73], has been recently suggested to be involved in OA pathogenesis as a protective factor [74,75].”
BackgroundBozzi, M., Sciandra, F., & Brancaccio, A. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.005 · Cited by 20
“Accordingly, an upregulation of the insulin growth factor and follistatin, both promoting skeletal muscle regeneration and growth [48,49], is observed [47].”
BackgroundVirtual High-Throughput Screening To Identify Novel Activin Antagonists
Zhu, J., Mishra, R. K., Schiltz, G. E., Makanji, Y., Scheidt, K. A., Mazar, A. P., & Woodruff, T. K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00753 · Cited by 21
Impaired Follistatin Secretion in Cirrhosis
Rinnov, A. R., Plomgaard, P., Pedersen, B. K., & Gluud, L. L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1923 · Cited by 20
“Follistatin is a negative regulator of the muscle-growth inhibitor myostatin (2, 4), and other muscle regulators of the transforming growth factor (TGF)family (5).”
Asari, T., Takayama, K., Nakamura, A., Shimada, T., Taguchi, A., & Hayashi, Y. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00420 · Cited by 20
Liu, Y., Lehar, A., Rydzik, R., Chandok, H., Lee, Y., Youngstrom, D. W., George, J., Matzuk, M. M., Germain‐Lee, E. L., & Lee, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111401118 · Cited by 21
“This fiber type shift is consistent with that seen in Fst +/ − mice (25) but to a greater degree.”
InfluentialSelf-citationde Mello, F., Streit, D. P., Sabin, N., & Gabillard, J. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.10.011 · Cited by 21
Panagiotou, G., Papakonstantinou, E., Vagionas, A., Pοlyzos, S. A., & Mantzoros, C. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01581 · Cited by 19
Shao, M., Shi, K., Zhao, Q., Duan, Y., Shen, Y., Tian, J., He, K., Li, D., Yu, M., Lu, Y., et al. (2022) · Genes · doi:10.3390/genes13050798 · Cited by 20
Vernerová, L., Horváthová, V., Kropáčková, T., Vokurková, M., Klein, M., Tomčík, M., Oreská, S., Špiritović, M., Štorkánová, H., Heřmánková, B., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/kez651 · Cited by 20
Pool, K., Rickard, J. P., & de Graaf, S. P. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106457 · Cited by 21
Knapp, M., Supruniuk, E., & Górski, J. (2023) · Biomolecules · doi:10.3390/biom13121777 · Cited by 19
“Myostatin additionally activates other intracellular pathways (noncanonical pathways), including, for instance, the suppression of Akt signaling cascade [7,8,10].”
BackgroundGrowth and differentiation factor 15 is a biomarker for low back pain-associated disability
Tarabeih, N., Shalata, A., Trofimov, S., Kalinkovich, A., & Livshits, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.011 · Cited by 22
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives
Mangner, N., Matsuo, Y., Schuler, G. C., & Adams, V. (2012) · Endocrine · doi:10.1007/s12020-012-9767-z · Cited by 18
McCoy, J. C., Walker, R. G., Murray, N. H., & Thompson, T. B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005831 · Cited by 21
“In other ligand antagonists, such as follistatin and FSTL3, FSDs play an important role in ligand binding and antagonism (32, 40, 50).”
BackgroundChain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice
Takayama, K., Asari, T., Saitoh, M., Nirasawa, K., Sasaki, E., Roppongi, Y., Nakamura, A., Saga, Y., Shimada, T., Ikeyama, H., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00174 · Cited by 17
Ciałowicz, M., Woźniewski, M., Murawska‐Ciałowicz, E., & Dzięgiel, P. (2025) · Cells · doi:10.3390/cells14161228 · Cited by 18
“In mouse models, follistatin has been shown to increase the skeletal muscle mass significantly [156,159].”
Boğa, S., Yildirim, A. E., Uçbılek, E., Köksal, A. R., Şişman, S. T., Durak, I., Şen, İ., Doğu, B., Serin, E., Ucbilek, A. B., et al. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002461 · Cited by 17
Absence of Hyperplasia inGasp-1Overexpressing Mice is Dependent on Myostatin Up-Regulation
Brun, C. E., Pèrié, L., Baraige, F., Vernus, B., Bonnieu, A., & Blanquet, V. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366335 · Cited by 21
O'Connell, K. E., Guo, W., Serra, C., Beck, M., Wachtman, L. M., Hoggatt, A. F., Xia, D., Pearson, C., Knight, H., O’Connell, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-257543 · Cited by 16
“Lee (56, 57) shown that genetic disruption of other members of the TGF-b/activin family, such as Activin A, in addition to myostatin, leads to more pronounced gains in muscle mass than disruption of myostatin alone.”
BackgroundThe transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs
Chang, F., Fang, R., Wang, M., Zhao, X., Chang, W., Zhang, Z., Li, N., & Meng, Q. (2016) · Transgenic Research · doi:10.1007/s11248-016-9985-x · Cited by 16
“However, the specific overexpression of follistatin in muscle tissue significantly increased the proportion of lean meat in the Duroc pigs studied here.”
BackgroundPalade, J., Djordjevic, D., Hutchins, E. D., George, R. M., Cornelius, J. A., Rawls, A., Ho, J. W. K., Kusumi, K., & Wilson‐Rawls, J. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.08.037 · Cited by 19
Kärst, S., Strucken, E. M., Schmitt, A. O., Weyrich, A., de Villena, F. P., Yang, H., & Brockmann, G. A. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-16 · Cited by 17
“In accordance with this, modifiers of myostatin, such as follistatin (Fst), which inhibits myostatin, are currently under review as therapeutics [18,19].”
BackgroundFormicola, L., Pannérec, A., Correra, R. M., Gayraud-Morel, B., Ollitrault, D., Besson, V., Tajbakhsh, S., Lachey, J. L., Seehra, J. S., Marazzi, G., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00515 · Cited by 18
“Semi-quantitative PCR analyses revealed that adult satellite cells express activinA and MST (Supplementary Figure 3A), which are factors known to inhibit myogenesis and induce muscle atrophy (McPherron et al., 1997; Lee et al., 2010).”
BackgroundSun, L., Lǚ, K., Liu, H., Wang, H., Li, X., Yang, C., Li, L., & Wang, J. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1581-2 · Cited by 29
“Decorin, a small leucine-rich proteoglycan, plays an important role in skeletal muscle mass via the promotion of protein synthesis and the inhibition of protein degradation [1].”
BackgroundActivinA activates Notch1-Shh signaling to regulate proliferation in C2C12 skeletal muscle cells
Ma, L., Li, C., Lian, S., Xu, B., Yuan, J., Lu, J., Yang, H., Guo, J., & Ji, H. L. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111055 · Cited by 16
Humińska‐Lisowska, K., Mieszkowski, J., Kochanowicz, A., Bojarczuk, A., Niespodziński, B., Brzezinska, P. B., Stankiewicz, B., Michałowska‐Sawczyn, M., Grzywacz, A., Petr, M., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148782 · Cited by 13
“Further, it has been reported that follistatin-like 1, a well-known promoter of skeletal muscle growth [16,17] is expressed in adipose tissue [18].”
BackgroundGene transcripts associated with muscle strength: a CHARGE meta-analysis of 7,781 persons
Pilling, L. C., Joehanes, R., Kacprowski, T., Peters, M. J., Jansen, R., Karasik, D., Kiel, D. P., Harries, L. W., Teumer, A., Powell, J. E., et al. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00054.2015 · Cited by 15
“Kelch proteins, including KLHL19, KLHL31, KLHL39m, and KLHDC1, are involved in skeletal muscle function and development (8); canonical and noncanonical Wnt signaling plays crucial roles in maintenance and development of skeletal muscle (7); insulin-like growth factors (IGFs) are also known to play roles in muscle grow…”
BackgroundMyostatin: genetic variants, therapy and gene doping
Yamada, A. K., Verlengia, R., & Júnior, C. R. B. (2012) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502012000300003 · Cited by 16
Vanderburg, C. R., & Clarke, M. S. F. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1538-x · Cited by 17
“In addition, related work suggests that the atrophic myostatin/activin receptor IIB pathway is capable of modulating the activity of the Akt/mTOR pathway [9].”
BackgroundRNA interference in Haliotis rufescens myostatin evidences upregulation of insulin signaling pathway
Carrera, C., Valenzuela‐Muñoz, V., Valdés, J. A., Molina, A., & Gallardo‐Escárate, C. (2016) · Agri Gene · doi:10.1016/j.aggene.2016.07.004 · Cited by 14
Myosteatosis: Epidemiological Insights, Functional Decline, and Diagnostic Advances
Zhang, Y., Jo, Y., Wei, S., Kim, Y., Park, W., Jeong, S.-J., Xue, Y., Lee, S. H., Kim, B., Oh, C., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00676-2 · Cited by 16
“Activin A, a TGF-β family member, similarly induces muscle wasting and fibrosis while impairing mesodermal differentiation [ 136].”
Self-citationDíaz, M., de Zegher, F., & Ibáñez, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125569 · Cited by 13
“Later on, follistatin was characterized as a reproductive hormone inhibiting the secretion of members of the transforming growth factor (TGF)-b family of proteins, including activin and inhibin, and as an enhancer of muscle mass through the inhibition of myostatin (7).”
BackgroundBAGHERI, N., Bagheri, R., Mesinovic, J., Ghobadi, H., Scott, D. S., Kargarfard, M., & Dutheil, F. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003592 · Cited by 19
Orioli, L., & Thissen, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554617 · Cited by 19
“FST inhibits several members of the TGF-beta family, including MSTN (222).”
Ceafalan, L. C., Manole, E., Tănase, C., Codrici, E., Mihai, S., Gonzalez, A., & Popescu, B. O. (2015) · The Anatomical Record · doi:10.1002/ar.23254 · Cited by 15
“In skeletal muscle it also regulates myogenesis during embryonic development and growth, as proved by studies performed on transgenic mice overexpressing FST (Lee et al., 2010).”
BackgroundPeake, J. M., Markworth, J. F., Cumming, K. T., Aas, S. N., Roberts, L. A., Raastad, T., Cameron‐Smith, D., & Figueiredo, V. C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00737 · Cited by 17
Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer
Qiu, W., Kuo, C., Tian, Y., & Su, G. H. (2021) · Biomedicines · doi:10.3390/biomedicines9070821 · Cited by 15
Freimuth, J., Clermont, F. F., Huang, X., DeSapio, A., Tokuyasu, T. A., Sheppard, D., & Akhurst, R. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205374109 · Cited by 15
“Intriguingly, activinA has been reported, like myostatin, to suppress muscle mass (31) and may therefore contribute to the lack of bronchiolar smooth muscle expansion and consequent reduced AHR in Tgfbm2/3 compared with NIH mice.”
BackgroundHosseini, S. R. A., Moienneia, N., & Rad, M. M. (2017) · Obesity Medicine · doi:10.1016/j.obmed.2017.01.004 · Cited by 15
“Myostatin is primarily released bymuscle cells and, in smaller amounts, by various tissues such as brain and fat tissue (Juhas and Bursac, 2014; Lutosławska et al., 2012) and is responsible for inhibiting the hypertrophic growth of muscle cells and preventing cell proliferation (growth inhibition of Hyperiolasic) (Lee…”
BackgroundInfluentialCritical analytical evaluation of promising markers for sarcopenia
Cavalier, E., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.11.002 · Cited by 12
“These markers have been chosen because they play a role in the linkage of muscle to bone [5–7], are associated with lean mass [8] or are regulators of muscle mass [9–11].”
BackgroundMultimodal learning for mapping genotype–phenotype dynamics
Khodaee, F., Zandie, R., & Edelman, E. R. (2025) · Nature Computational Science · doi:10.1038/s43588-024-00765-7 · Cited by 14
“It plays an important role in muscle growth, wound healing and reproductive processes 23 .”
Abdel-Raouf, K. M. A., Rezgui, R., Stefanini, C., Teo, J. C. M., & Christoforou, N. (2021) · Biology · doi:10.3390/biology10060539 · Cited by 14
“Our findings also describe the ineffectiveness of Follistatin, GDF8, hGH, in addition to the very limited impact of GDF11, GDF15, TMSB4X, and IL6.”
BackgroundInfluentialIdentification of TGF-β, inhibin βA and follistatin paralogs in the rainbow trout genome
de Mello, F., Streit, D. P., Sabin, N., & Gabillard, J. (2014) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2014.07.006 · Cited by 12
“Similarly, mice knocked out for inhibin βA exhibit a double-muscled phenotype (Lee et al., 2010).”
BackgroundJin, Q., Qiao, C., Li, J., Li, J., & Xiao, X. (2019) · Gene Therapy · doi:10.1038/s41434-019-0107-2 · Cited by 11
Myostatin's marvels: From muscle regulator to diverse implications in health and disease
Sharma, S., & Patil, A. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4106 · Cited by 13
Characterization of tolloid-mediated cleavage of the GDF8 procomplex
McCoy, J. C., Goebel, E. J., & Thompson, T. B. (2021) · Biochemical Journal · doi:10.1042/bcj20210054 · Cited by 11
Welsh, B. T., Cote, S. M., Meshulam, D., Jackson, J., Pal, A., Lansita, J. A., & Kalra, A. V. (2021) · International Journal of Toxicology · doi:10.1177/10915818211025477 · Cited by 12
Zhong, S.-S., Jiang, X., Sun, C., & Zou, S. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.01.016 · Cited by 10
Expression of follistatin is associated with egg formation in the oviduct of laying hens
Wasti, S., Sah, N., Kuehu, D. L., Kim, Y. S., Jha, R., & Mishra, B. (2020) · Animal Science Journal · doi:10.1111/asj.13396 · Cited by 13
Wu, R., Wang, P., Yang, L., Li, Y., Liu, Y., & Liu, M. (2011) · Genetics and Molecular Research · doi:10.4238/2011.october.21.7 · Cited by 12
“It has been reported that skeletal muscle atrophy is associated with an increased expression of myostatin (Whittemore et al., 2003; Lee et al., 2010).”
BackgroundHorváth, L., Pekár, M., Švagera, Z., Horká, V., Mráz, M., & Bužga, M. (2025) · Physiological Research · doi:10.33549/physiolres.935751 · Cited by 22
Comprehensive proteomic analysis of buffalo milk extracellular vesicles
Joshi, M., Sharma, S., Onteru, S. K., & Singh, D. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136735 · Cited by 10
Circulating follistatin in the human foetus at term birth
Sebastiani, G., Díaz, M., López‐Bermejo, A., Arranz, Á., de Zegher, F., & Ibáñez, L. (2011) · Pediatric Obesity · doi:10.1111/j.2047-6310.2011.00004.x · Cited by 10
“Mice homozygous for loss-of-function mutations in the follistatin gene have a reduced amount of muscle tissue, suggesting that follistatin also participates in myogenesis (9).”
BackgroundSchalt, A., Johannsen, M., Kim, J., Chen, R., Murphy, C. J., Coker, M. S., Gunga, H., Coker, R. H., & Steinach, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01761 · Cited by 10
Dushyanth, K., Shukla, R., CHATTERJEE, R. N., & Bhattacharya, T. K. (2020) · Animal Biotechnology · doi:10.1080/10495398.2020.1838917 · Cited by 10
Kong, W. G. B. B.-W. (2014) · Biochemistry & Physiology Open Access · doi:10.4172/2168-9652.1000125 · Cited by 15
“FOXO Forkhead box O3 - protein and cellular component degradation by FOXO is inhibited by Akt-mediated repression of FOXO transcription factors [13,32] mTORC2 mammalian target of rapamycin protein complex 2 - increases phosphorylation of Akt (protein kinase B) [28] Rheb Ras homolog enriched in brain - increases activa…”
BackgroundPharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids
Jain, M., Mohankumar, A., Torres, J., & Alkorbi, H. A. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.01.017 · Cited by 11
Zhang, C., Wang, J. J., He, X., Wang, C., Zhang, B., Xu, J., Xu, W., Luo, Y., & Huang, K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000496042 · Cited by 10
Li, M., Tang, X., You, W., Wang, Y., Chen, Y., Liu, Y., Yuan, H., Gao, C., Chen, X., Xiao, Z., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.06.011 · Cited by 10
Serum Sestrin-1 Concentration Is Higher in Frail than Non-Frail Older People Living in Nursing Homes
Sanz, B., Rezola‐Pardo, C., Arrieta, H., Fraile-Bermúdez, A. B., Alonso-Puyo, J., Molano, I., Rodriguez‐Larrad, A., & Irazusta, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031079 · Cited by 9
Through Thick and Thin: A Circulating Growth Factor Inhibits Age-Related Cardiac Hypertrophy
McPherron, A. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.302239 · Cited by 10
Lee, S.-J. (2012) · Muscle · doi:10.1016/b978-0-12-381510-1.00079-x · Cited by 8
Self-citation
Metadata
- Authors
- Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R.
- Affiliations
- Johns Hopkins University (US)
- University of Miami (US)
- Baylor College of Medicine (US)
- Fujita Health University (JP)
- University of Pennsylvania (US)
- ORCID
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-10-01
- Volume
- 24
- Issue
- 10
- Pages
- 1998-2008
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC2954636
- OpenAlex
- W2029816532
- Semantic Scholar
- 50765d8f8086769e58ab3497a6b5260266268e0b
- Cited by
- 273
- References
- 64
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 16 · 2018: 13 · 2017: 13 · 2016: 22 · 2015: 21 · 2014: 18 · 2013: 21 · 2012: 22
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (1dp2od004515-01)
- National Institute on Aging (R01AG037193)
- National Cancer Institute (R01CA122596)
- National Institute of General Medical Sciences (R01GM092758)
- National Institute of Neurological Disorders and Stroke (K08NS055879)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR052646, R01AR060636, R01AR059685)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD032067)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- follistatin, myostatin, activin A, TGF-beta superfamily, skeletal muscle mass, muscle fiber type shift, muscle remodeling, tetanic force, muscle atrophy, muscle degeneration, muscle growth
- MeSH terms
- Animals, Humans, Mice, Inbred C57BL, Muscle Contraction, Organ Size, Mice, Knockout, Muscle, Skeletal, Muscle Development, Activins, Follistatin, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.